Free Trial

Aurora Cannabis (ACB) Competitors

Aurora Cannabis logo
C$7.21 -0.21 (-2.83%)
As of 05/21/2025 04:00 PM Eastern

ACB vs. THCX, CRON, GUD, TLRY, WEED, FIRE, EPI, CPH, ICC, and OGI

Should you be buying Aurora Cannabis stock or one of its competitors? The main competitors of Aurora Cannabis include Hydropothecary (THCX), Cronos Group (CRON), Knight Therapeutics (GUD), Tilray Brands (TLRY), Canopy Growth (WEED), Supreme Cannabis (FIRE), ESSA Pharma (EPI), Cipher Pharmaceuticals (CPH), ICC Labs (ICC), and Organigram (OGI). These companies are all part of the "drug manufacturers - specialty & generic" industry.

Aurora Cannabis vs.

Hydropothecary (CVE:THCX) and Aurora Cannabis (TSE:ACB) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, institutional ownership, dividends, community ranking, media sentiment, profitability, analyst recommendations, risk and valuation.

Aurora Cannabis received 390 more outperform votes than Hydropothecary when rated by MarketBeat users. However, 72.31% of users gave Hydropothecary an outperform vote while only 63.14% of users gave Aurora Cannabis an outperform vote.

CompanyUnderperformOutperform
HydropothecaryOutperform Votes
141
72.31%
Underperform Votes
54
27.69%
Aurora CannabisOutperform Votes
531
63.14%
Underperform Votes
310
36.86%

13.4% of Aurora Cannabis shares are owned by institutional investors. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

In the previous week, Hydropothecary's average media sentiment score of 0.00 equaled Aurora Cannabis'average media sentiment score.

Company Overall Sentiment
Hydropothecary Neutral
Aurora Cannabis Neutral

Aurora Cannabis has a consensus price target of C$8.75, suggesting a potential upside of 21.36%. Given Aurora Cannabis' stronger consensus rating and higher possible upside, analysts clearly believe Aurora Cannabis is more favorable than Hydropothecary.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hydropothecary
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Aurora Cannabis
0 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
2 Strong Buy rating(s)
3.33

Hydropothecary has higher earnings, but lower revenue than Aurora Cannabis.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
HydropothecaryN/AN/AN/AN/AN/A
Aurora CannabisC$195.83M2.01-C$44.16M-C$0.81-8.90

Hydropothecary has a net margin of 0.00% compared to Aurora Cannabis' net margin of -22.55%. Hydropothecary's return on equity of 0.00% beat Aurora Cannabis' return on equity.

Company Net Margins Return on Equity Return on Assets
HydropothecaryN/A N/A N/A
Aurora Cannabis -22.55%-8.36%-1.87%

Summary

Aurora Cannabis beats Hydropothecary on 6 of the 10 factors compared between the two stocks.

Get Aurora Cannabis News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACB and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACB vs. The Competition

MetricAurora CannabisDrug Manufacturers IndustryMedical SectorTSE Exchange
Market CapC$394.45MC$2.17BC$5.37BC$5.94B
Dividend YieldN/A2.92%5.22%6.32%
P/E Ratio-8.903.9826.8429.95
Price / Sales2.01529.96392.34752.53
Price / Cash1.2510.2538.2583.71
Price / Book0.656.926.793.96
Net Income-C$44.16MC$20.70BC$3.23BC$301.32M
7 Day Performance4.34%-0.40%1.53%0.84%
1 Month Performance22.20%4.82%10.05%7.48%
1 Year Performance-23.13%89.72%16.71%16.03%

Aurora Cannabis Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACB
Aurora Cannabis
0.8009 of 5 stars
C$7.21
-2.8%
C$8.75
+21.4%
-25.8%C$394.45MC$195.83M-8.901,073
THCX
Hydropothecary
N/AC$5.30
+6.6%
N/A+0.0%C$949.11MN/A0.00N/AHigh Trading Volume
CRON
Cronos Group
N/AC$2.86
+3.6%
C$3.54
+23.8%
-24.5%C$755.23MC$76.86M-15.91450
GUD
Knight Therapeutics
1.5714 of 5 stars
C$5.86
+2.6%
C$7.15
+22.0%
-5.1%C$592.74MC$348.70M-19.56725
TLRY
Tilray Brands
N/AC$0.64
+8.5%
N/A-76.8%C$412.40MC$610.34M-1.552,650
WEED
Canopy Growth
1.4895 of 5 stars
C$2.05
+12.6%
C$5.64
+175.0%
-82.0%C$329.78MC$519.68M-0.302,700Positive News
FIRE
Supreme Cannabis
N/AN/AN/AN/AC$259.40MC$53.29M-10.97400
EPI
ESSA Pharma
N/AC$8.20
+7.2%
N/A+0.0%C$237.87MN/A-8.2725
CPH
Cipher Pharmaceuticals
1.6275 of 5 stars
C$13.20
-5.1%
C$14.75
+11.7%
+36.3%C$236.98MC$19.03M14.585
ICC
ICC Labs
N/AC$1.62
-5.8%
N/A+0.0%C$223.64MC$533,684.0095.29N/AGap Up
OGI
Organigram
3.1182 of 5 stars
C$1.80
+9.8%
C$3.67
+103.7%
-28.5%C$222.38MC$180.58M-3.81987Gap Down

Related Companies and Tools


This page (TSE:ACB) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners